A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC

NCT02378870 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Poor patient recruitment

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: Osteodex
DRUG: Placebo

Sponsor

DexTech Medical AB